Medical Oncologist
Metastatic breast cancer
Treatment sequence in metastatic HER2-positive breast cancer
Metastatic HER2-positive breast cancer is usually treated in a sequence: two HER2 antibodies with chemotherapy first, then antibody-drug conjugates, then HER2 tablets and other combinations. Heart checks run throughout. This page maps the typical order and daily life on treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What is the usual treatment sequence for metastatic HER2-positive breast cancer?
- Types of HER2-targeted treatment
- A typical sequence, in general terms
- The vocabulary, in plain language
- Honest expectations with HER2-positive metastatic disease
- Looking after your heart and lungs during treatment
- Living well on long-term HER2 treatment
- Questions to ask about HER2 treatment
- When cancer is both HER2-positive and hormone receptor positive
- Why brain spread is watched closely
- What people assume about HER2-positive metastatic disease
- Common questions about HER2 treatment sequence
The short answer
What is the usual treatment sequence for metastatic HER2-positive breast cancer?
HER2-positive breast cancer makes too much of a protein called HER2, which drives cancer growth. Before HER2-targeted medicines existed, this type of cancer had a poor outlook. Today, metastatic HER2-positive breast cancer is one of the types where treatment has improved the most, and many people live for years with the cancer under control. Treatment is usually given in a sequence of lines. First-line treatment generally combines two HER2-targeted antibodies with a chemotherapy medicine, given through a drip. After several months, chemotherapy is often stopped while the two antibodies continue as maintenance, sometimes with hormone therapy added if the cancer is also hormone receptor positive. When the cancer grows, second-line treatment is commonly a HER2 antibody-drug conjugate, which carries a powerful chemotherapy directly into HER2-positive cells. Later lines may include another antibody-drug conjugate, HER2-targeted tablets combined with other medicines, or further antibody and chemotherapy combinations. Brain metastases are more common in this type, so some sequences are chosen partly for their activity in the brain.
Confirming HER2 status
A biopsy of a metastatic area, when possible, confirms the cancer is still HER2-positive and rechecks hormone receptors, as both guide treatment.
Heart monitoring
Some HER2-targeted medicines can affect heart pumping, so an echocardiogram is usually done before starting and repeated every few months.
Treatment can continue for a long time
Maintenance with HER2-targeted antibodies can continue for years in people whose cancer stays controlled.
This page gives general information only. Your oncologist will plan the sequence that suits you.The treatment families
Types of HER2-targeted treatment
Each works against HER2 in a different way.
HER2 antibodies
Proteins that attach to HER2 on cancer cells and block growth signals, given by drip or injection under the skin.
Antibody-drug conjugates
A HER2 antibody linked to chemotherapy, delivering treatment directly into cancer cells.
Lung inflammation is a rare but important side effect.HER2 tablets
Small-molecule tablets that block HER2 signals from inside the cell, some of which reach the brain.
Combination partners
Medicines given alongside HER2 treatment.
These can include
- Chemotherapy
- Hormone therapy for hormone-positive cancers
- Bone-strengthening medicines
A general map
A typical sequence, in general terms
Line
Commonly used approach
First line
Two HER2 antibodies with chemotherapy, then antibodies continued as maintenance
Second line
A HER2 antibody-drug conjugate
Third line and beyond
HER2 tablets with an antibody and chemotherapy, another antibody-drug conjugate, or other combinations
Hormone-positive as well
Hormone therapy may be added during maintenance
Brain metastases
Local brain treatment plus medicines with brain activity
Not sure whether this applies to you?
Ask an oncologistWords you will hear
The vocabulary, in plain language
- HER2-positive
- Cancer with high levels of the HER2 protein or extra copies of the HER2 gene.
- Dual HER2 blockade
- Using two HER2 antibodies together for a stronger effect.
- Antibody-drug conjugate
- An antibody that carries chemotherapy into cancer cells.
- Tyrosine kinase inhibitor
- A tablet that blocks growth signals inside the cell.
- Echocardiogram
- An ultrasound scan of the heart to check its pumping.
- Maintenance
- Continuing targeted treatment after chemotherapy stops.
Being straight with you
Honest expectations with HER2-positive metastatic disease
The progress in treating HER2-positive metastatic breast cancer is real, but it is still a serious condition that usually needs lifelong treatment.
Outcomes vary widely
Some people stay on first-line maintenance for many years, while others move through lines more quickly. Your team can give a more personal picture.
Side effects need attention
Loose motions, tiredness, nausea, heart effects and, with antibody-drug conjugates, rare lung inflammation need monitoring and early reporting.
Access and cost
Newer HER2 medicines can be expensive. Biosimilar antibodies have improved access, and patient programmes may help with others. Ask about options.
The brain needs watching
Because brain spread is more common, report headaches, weakness or confusion promptly.
What this page cannot tell you
It cannot plan your sequence. Ask your oncologist what comes next for you.
Safety checks
Looking after your heart and lungs during treatment
HER2-targeted treatments are generally well tolerated, but two safety areas need regular attention.
Heart pumping
HER2 antibodies can reduce how strongly the heart pumps in a small number of people. It is usually reversible when treatment is paused. Echocardiograms are done before and during treatment.
Heart symptoms to report
Tell your team about breathlessness lying flat, swelling of the ankles, a racing heartbeat or unusual tiredness.
Lung inflammation
Some antibody-drug conjugates can rarely cause inflammation of the lungs. Report a new cough, breathlessness or fever promptly, as early treatment matters.
Protecting your heart
Controlling blood pressure, diabetes and cholesterol, staying active and not smoking all help heart health.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Daily life
Living well on long-term HER2 treatment
Many people on maintenance HER2 treatment return to work, travel and family life between treatments.
Treatment schedules
Maintenance antibodies are usually given every three weeks. Injections under the skin can shorten hospital visits. Ask whether visits can fit around work.
Managing loose motions
HER2 tablets often cause loose motions. Anti-diarrhoea medicines, fluids and diet changes help. Report severe or persistent symptoms.
Keeping a record
Note each treatment, dates, heart scan results and side effects to share with any doctor you see.
Emotional wellbeing
Long-term treatment can bring worry about scans and the future. Counselling and support groups help.
At your appointment
Questions to ask about HER2 treatment
Written questions help you understand both the current step and what lies ahead.
About the current line
Why is this treatment recommended now? How often will heart scans and other scans be done? Which side effects need urgent attention?
About the next steps
What options are likely if this stops working? Should I have a brain MRI if I develop symptoms?
About access
Are biosimilars or patient access programmes available for my treatment?
Two receptors
When cancer is both HER2-positive and hormone receptor positive
About half of HER2-positive breast cancers also have hormone receptors. This is sometimes called triple positive breast cancer, and it gives your team extra options for long-term control.
Adding hormone therapy
After chemotherapy is stopped, hormone therapy is often added to maintenance HER2 antibodies. For women before menopause, the ovaries are also switched off. This can help keep the cancer controlled for longer without further chemotherapy.
Choosing a gentler start
For some people who are frail or have slow-growing cancer, HER2-targeted treatment combined with hormone therapy may be considered instead of chemotherapy at first.
Side effects to expect
Hormone therapy can add hot flushes, joint aches and bone thinning, which can be managed with exercise, calcium and vitamin D when advised, and bone medicines.
Brain health
Why brain spread is watched closely
HER2-positive breast cancer spreads to the brain more often than some other types. This can happen even when cancer elsewhere is well controlled, because many medicines do not easily reach the brain.
Symptoms to report
New headaches, especially in the morning, weakness or numbness on one side, changes in vision, balance, speech or behaviour, and seizures all need prompt review.
How it is treated
Focused radiation, surgery for larger single spots, and medicines with activity in the brain are often combined, and many people continue their HER2 treatment for the rest of the body.
Scans
A brain MRI is arranged when symptoms appear, and some doctors consider it at other times for people at higher risk.
Commonly believed
What people assume about HER2-positive metastatic disease
HER2-positive cancer always has a poor outlook.
Targeted treatments have transformed outcomes for many people.
Once chemotherapy stops, treatment is over.
HER2 antibodies usually continue as maintenance.
Heart effects are permanent.
Heart pumping changes usually recover when treatment is paused.
Biosimilars are weaker copies.
Approved biosimilars are tested to work in the same way.
Questions we are asked
Common questions about HER2 treatment sequence
How long does maintenance treatment last?
As long as it controls the cancer and the heart stays healthy, sometimes for many years.
Will I lose my hair?
Hair loss is common with chemotherapy and some antibody-drug conjugates, but not with antibodies alone.
Can HER2-positive cancer become HER2-negative?
Occasionally, which is why a biopsy at progression may be advised.
Do HER2 medicines reach the brain?
Some HER2 tablets and antibody-drug conjugates have activity in the brain.
Can I work during maintenance?
Many people do, with treatment every few weeks.
Is hormone therapy added?
Often, if the cancer is also hormone receptor positive.
Can I get a second opinion?
Yes. Bring pathology, scans and heart scan reports.
Who helps with cost?
Financial counsellors can explain schemes and access programmes.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- American Society of Clinical Oncology — Systemic therapy for advanced HER2-positive breast cancer guideline
- European Society for Medical Oncology — Metastatic breast cancer clinical practice guideline
- National Cancer Institute — Breast cancer treatment (PDQ)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.